Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

AstraZeneca plc’s Dividend Prospects For 2014 And Beyond

| G A Chester

G A Chester analyses the income outlook for AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

Is AstraZeneca plc Still A Buy After The 2013 FTSE Bull Run?

| Roland Head

AstraZeneca plc (LON:AZN) has kept pace with the FTSE this year, but remains an appealing recovery story.

Read more »

Investing Articles

3 FTSE Shares Hitting New Highs: Drax Group Plc, Smith & Nephew plc and AstraZeneca plc

| Alan Oscroft

Drax Group Plc (LON: DRX), Smith & Nephew plc (LON: SN) and AstraZeneca plc (LON: AZN) are soaring.

Read more »

Investing Articles

AstraZeneca plc Could Help You Retire Early

| Peter Stephens

Retirement may not be so long away for shareholders in AstraZeneca plc (LON: AZN). Here’s why...

Read more »

Investing Articles

Can AstraZeneca plc’s Share Price Return To 3,625p?

| Rupert Hargreaves

Will AstraZeneca plc (LON: AZN) be able to return to its previous highs?

Read more »

Investing Articles

The Warren Buffett Bear Case For AstraZeneca plc

| G A Chester

A Buffett fan considers the investment case for AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

AstraZeneca plc Could Be Worth 3915p

| Peter Stephens

Shareholders in AstraZeneca plc (LON: AZN) could enjoy gains of 18.5% plus a generous dividend. Here’s why…

Read more »

Investing Articles

Why AstraZeneca plc Will Be One Of 2013’s Winners

| Alan Oscroft

It's a close run for AstraZeneca plc (LON: AZN) as we approach the end of the year.

Read more »

Investing Articles

A SWOT Analysis Of AstraZeneca Plc And GlaxoSmithKline plc

| David O'Hara

What are the key factors affecting the investment proposition at pharmaceutical giants GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN)?

Read more »

Investing Articles

Angels vs Devils: Should You Invest In AstraZeneca plc?

| Royston Wild

Royston Wild considers the pros and cons of investing in AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

This Model Suggests AstraZeneca plc Could Deliver A 6.3% Annual Return

| Roland Head

Roland Head explains why AstraZeneca plc (LON:AZN) could deliver a 6.3% annual return over the next few years.

Read more »

Company Comment

AstraZeneca Plc’s Turnaround Story Hasn’t Started Yet

| Keith Speights

The turnaround story at AstraZeneca plc (LON:AZN) may require a good deal more time to even begin...

Read more »